NASDAQ · Financial Statements
BioRestorative Therapies, Inc. (BRTX) Financial Statements
$1.91
NASDAQ: BRTX
Market Cap $2.64M
Overview Financials Dividend BioRestorative Therapies, Inc. most recently reported annual revenue of $0, net profit of $-14.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-26.0M $-19.0M $-15.0M $-12.0M $-16.0M Net Profit $-44.0M $-13.0M $-10.0M $-9.0M $-14.0M EPS $-746.00 $-73.00 $-49.40 $-23.20 $-31.60 Op Margin -57191.0% -15745.8% -10439.5% -2881.6% -4350.1%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $22.0M $16.0M $13.0M $12.0M $4.0M Total Liabilities $1.0M $6.0M $3.0M $4.0M $4.0M Cash $21.0M $2.0M $1.0M $1.0M $2.0M Borrowings $1.0M $0 $0 $0 $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-3.0M $-6.0M $-6.0M $-8.0M $-11.0M Investing Cash Flow $0 $-14.0M $3.0M $0 $9.0M Financing Cash Flow $0 $0 $0 $7.0M $0 Net Cash Flow $18.0M $-19.0M $-1.0M $0 $1.0M Free Cash Flow $-3.0M $-6.0M $-7.0M $-8.0M $-11.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.01 EV / EBITDA 0.00 FCF Yield -384.57% Quick Ratio 2.35 Interest Coverage 0.00 Return 1Y -77.92% Return 3Y -89.60% Return 5Y -98.30%
Screens featuring this stock